Literature DB >> 28498887

Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study.

Joshua Matyi1, JoAnn T Tschanz1,2, Gail B Rattinger3, Chelsea Sanders1, Elizabeth K Vernon1, Chris Corcoran4, John S K Kauwe5, Mona Buhusi1.   

Abstract

Neurotrophins, including nerve-growth factor and brain-derived neurotrophic factor, have been implicated in Alzheimer's disease (AD). Associations between AD and neurotrophin signaling genes have been inconsistent, with few studies examining sex differences in risk. We examined four single-nucleotide polymorphisms (SNPs) involved in neurotrophin signaling (rs6265, rs56164415, rs2289656, rs2072446) and risk for AD by sex in a population-based sample of older adults. Three thousand four hundred and ninety-nine individuals without dementia at baseline [mean (standard deviation) age = 74.64 (6.84), 58% female] underwent dementia screening and assessment over four triennial waves. Cox regression was used to examine time to AD or right censoring for each SNP. Female carriers of the minor T allele for rs2072446 and rs56164415 had a 60% (hazard ratio [HR] = 1.60, 95% confidence interval [CI] = 1.02-2.51) and 93% (HR = 1.93, 95% CI = 1.30-2.84) higher hazard for AD, respectively, than male noncarriers of the T allele. Furthermore, male carriers of the T allele of rs2072446 had a 61% lower hazard (HR = 0.39, 95% CI = 0.14-1.06) than male noncarriers at trend-level significance (p = .07). The association between certain neurotrophin gene polymorphisms and AD differs by sex and may explain inconsistent findings in the literature.
© The Author 2017. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Nerve growth factor; Single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2017        PMID: 28498887      PMCID: PMC5861928          DOI: 10.1093/gerona/glx092

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  61 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

3.  Is the risk of developing Alzheimer's disease greater for women than for men?

Authors:  L E Hebert; P A Scherr; J J McCann; L A Beckett; D A Evans
Journal:  Am J Epidemiol       Date:  2001-01-15       Impact factor: 4.897

4.  No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.

Authors:  Marika S Saarela; Terho Lehtimaki; Juha O Rinne; Heini Huhtala; Riika Rontu; Antti Hervonen; Matias Roytta; Jukka-Pekka Ahonen; Kari M Mattila
Journal:  Folia Neuropathol       Date:  2006       Impact factor: 2.038

5.  7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.

Authors:  Latha Devi; Masuo Ohno
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

Review 6.  Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond.

Authors:  Breno Satler Diniz; Antonio Lucio Teixeira
Journal:  Neuromolecular Med       Date:  2011-09-07       Impact factor: 3.843

Review 7.  Neurotrophins and neurodegeneration.

Authors:  D Dawbarn; S J Allen
Journal:  Neuropathol Appl Neurobiol       Date:  2003-06       Impact factor: 8.090

Review 8.  BDNF and memory processing.

Authors:  Pedro Bekinschtein; Martin Cammarota; Jorge H Medina
Journal:  Neuropharmacology       Date:  2013-05-18       Impact factor: 5.250

9.  Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.

Authors:  F Miyajima; W Ollier; A Mayes; A Jackson; N Thacker; P Rabbitt; N Pendleton; M Horan; A Payton
Journal:  Genes Brain Behav       Date:  2007-10-31       Impact factor: 3.449

10.  Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum.

Authors:  Sofia Grade; Yuan C Weng; Marina Snapyan; Jasna Kriz; João O Malva; Armen Saghatelyan
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more
  6 in total

Review 1.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 2.  Sex differences in Alzheimer's disease: Understanding the molecular impact.

Authors:  Carlos A Toro; Larry Zhang; Jiqing Cao; Dongming Cai
Journal:  Brain Res       Date:  2019-05-23       Impact factor: 3.252

3.  Association between the Val66Met polymorphism (rs6265/G196A) of the BDNF gene and cognitive performance with SSRI use in Arab Alzheimer's disease patients.

Authors:  N Abanmy; J Alsabhan; P Gard; G Scutt
Journal:  Saudi Pharm J       Date:  2021-10-25       Impact factor: 4.330

4.  Interaction Between Physical Activity and Genes Related to Neurotrophin Signaling in Late-Life Cognitive Performance: The Cache County Study.

Authors:  Chelsea L Sanders; Gail B Rattinger; M Scott Deberard; Alexandra G Hammond; Heidi Wengreen; John S K Kauwe; Mona Buhusi; Joann T Tschanz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-16       Impact factor: 6.053

5.  BDNF Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females.

Authors:  Inmaculada C Rodríguez-Rojo; Pablo Cuesta; María Eugenia López; Jaisalmer de Frutos-Lucas; Ricardo Bruña; Ernesto Pereda; Ana Barabash; Pedro Montejo; Mercedes Montenegro-Peña; Alberto Marcos; Ramón López-Higes; Alberto Fernández; Fernando Maestú
Journal:  Front Neurosci       Date:  2018-10-02       Impact factor: 4.677

6.  Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice.

Authors:  Vladimir Ilievski; Paulina K Zuchowska; Stefan J Green; Peter T Toth; Michael E Ragozzino; Khuong Le; Haider W Aljewari; Neil M O'Brien-Simpson; Eric C Reynolds; Keiko Watanabe
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.